0001179110-15-006097.txt : 20150408 0001179110-15-006097.hdr.sgml : 20150408 20150408161825 ACCESSION NUMBER: 0001179110-15-006097 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20150406 FILED AS OF DATE: 20150408 DATE AS OF CHANGE: 20150408 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: SYNTA PHARMACEUTICALS CORP CENTRAL INDEX KEY: 0001157601 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 45 HARTWELL AVE CITY: LEXINGTON STATE: MA ZIP: 02421 BUSINESS PHONE: 781-274-8200 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Gollust Keith R CENTRAL INDEX KEY: 0001325712 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-33277 FILM NUMBER: 15759279 MAIL ADDRESS: STREET 1: C/O SYNTA PHARMACEUTICALS CORP. STREET 2: 45 HARTWELL AVENUE CITY: LEXINGTON STATE: MA ZIP: 02421 4 1 edgar.xml FORM 4 - X0306 4 2015-04-06 0 0001157601 SYNTA PHARMACEUTICALS CORP SNTA 0001325712 Gollust Keith R C/O SYNTA PHARMACEUTICALS CORP. 45 HARTWELL AVENUE LEXINGTON MA 02421 1 0 0 0 Common Stock 2015-04-06 4 P 0 350000 1.75 A 3173383 I By Wyandanch Partners, L.P. Common Stock 351766 D Common Stock 175000 I By Keith R. Gollust IRA The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, if any, and the inclusion of these shares in this report shall not be deemed an admission of the beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose. /s/ Garrett M. Winslow, Attorney-in-Fact 2015-04-08